A promising therapeutic approach currently pursued against prion diseases (that could likewise be beneficial in other neurodegenerative diseases) is to reduce the overall expression of PrP via antisense oligonucleotides (Minikel et al. 2020; Raymond et al. 2019; Vallabh et al. 2019). Here, PRNP is linked to neurodegenerative disease.